Clinical Trial Detail

NCT ID NCT02188550
Title Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors Sinai Hospital of Baltimore
Indications

fallopian tube carcinoma

ovary epithelial cancer

endometrial cancer

peritoneal carcinoma

Therapies

Everolimus + Letrozole

Age Groups: adult

No variant requirements are available.